SCHEMBL14343036

SCHEMBL14343036

CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OCF)cc1)C(=O)OC(C1CC1)C1CC1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 1/20 0.49
▸ ITGA2B P08514 1/20 0.49
▸ HDAC8 Q9BY41 1/20 0.48
▸ CTSS P25774 6/20 0.44
▸ CTSK P43235 5/20 0.44
▸ BCL2 P10415 1/20 0.44
▸ PTPN1 P18031 3/20 0.43
▸ CACNA1B Q00975 3/20 0.42
▸ HRH2 P25021 1/20 0.42
▸ HRH1 P35367 1/20 0.42
▸ YAP1 P46937 1/20 0.42
▸ CTSL P07711 1/20 0.41
▸ CTSB P07858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16173550 1.00 ITGB3 (0.49) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL14343090 1.00 ITGB3 (0.49) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL16173548 1.00 ITGB3 (0.49) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL16173579 0.92 ITGB3 (0.51) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL16173577 0.92 ITGB3 (0.51) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL14343048 0.89 ITGB3 (0.48) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL16173549 0.89 ITGB3 (0.48) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL14343069 0.89 ITGB3 (0.45) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL14343099 0.89 ITGB3 (0.45) ITGB3ITGA2BHDAC8CTSSCTSK
SCHEMBL14343166 0.86 CTSS (0.56) ITGB3ITGA2BHDAC8CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140309424-A1 DIRECT SYNTHESIS OF 18F-FLUOROMETHOXY COMPOUNDS FOR PET IMAGING AND THE PROVISION OF NEW PRECURSORS FOR DIRECT RADIOSYNTHESIS OF PROTECTED DERIVATIVES OF O-([18F] FLUOROMETHYL) TYROSINE PIRAMAL IMAGING SA (CH) 2014-10-16 — — US claimed
EP-2540710-A1 New precursors for direct radiosynthesis of protected derivatives of O-([18F]Fluoromethyl) tyrosine Bayer Schering Pharma Aktiengesellschaft (DE) 2013-01-02 — — EP claimed
US-20140309424-A1 DIRECT SYNTHESIS OF 18F-FLUOROMETHOXY COMPOUNDS FOR PET IMAGING AND THE PROVISION OF NEW PRECURSORS FOR DIRECT RADIOSYNTHESIS OF PROTECTED DERIVATIVES OF O-([18F] FLUOROMETHYL) TYROSINE PIRAMAL IMAGING SA (CH) 2014-10-16 — — US disclosed
US-20140309424-A1 DIRECT SYNTHESIS OF 18F-FLUOROMETHOXY COMPOUNDS FOR PET IMAGING AND THE PROVISION OF NEW PRECURSORS FOR DIRECT RADIOSYNTHESIS OF PROTECTED DERIVATIVES OF O-([18F] FLUOROMETHYL) TYROSINE PIRAMAL IMAGING SA (CH) 2014-10-16 — — US disclosed
US-20140309424-A1 DIRECT SYNTHESIS OF 18F-FLUOROMETHOXY COMPOUNDS FOR PET IMAGING AND THE PROVISION OF NEW PRECURSORS FOR DIRECT RADIOSYNTHESIS OF PROTECTED DERIVATIVES OF O-([18F] FLUOROMETHYL) TYROSINE PIRAMAL IMAGING SA (CH) 2014-10-16 — — US disclosed
EP-2540710-A1 New precursors for direct radiosynthesis of protected derivatives of O-([18F]Fluoromethyl) tyrosine Bayer Schering Pharma Aktiengesellschaft (DE) 2013-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309424-A1 DIRECT SYNTHESIS OF 18F-FLUOROMETHOXY COMPOUNDS FOR PET IMAGING AND THE PROVISION OF NEW PRECURSORS FOR DIRECT RADIOSYNTHESIS OF PROTECTED DERIVATIVES OF O-([18F] FLUOROMETHYL) TYROSINE TH, TYR, FTO ITGB3 2717/4885ITGA2B 3431/4885HDAC8 4686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback